nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2A6—Prednisolone—ankylosing spondylitis	0.275	0.383	CbGbCtD
Formoterol—CYP2A6—Dexamethasone—ankylosing spondylitis	0.162	0.226	CbGbCtD
Formoterol—CYP2C19—Prednisone—ankylosing spondylitis	0.108	0.15	CbGbCtD
Formoterol—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0671	0.0934	CbGbCtD
Formoterol—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0558	0.0776	CbGbCtD
Formoterol—CYP2D6—Dexamethasone—ankylosing spondylitis	0.051	0.071	CbGbCtD
Formoterol—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000699	0.00249	CcSEcCtD
Formoterol—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000689	0.00245	CcSEcCtD
Formoterol—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000686	0.00244	CcSEcCtD
Formoterol—Visual impairment—Betamethasone—ankylosing spondylitis	0.000686	0.00244	CcSEcCtD
Formoterol—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000686	0.00244	CcSEcCtD
Formoterol—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000682	0.00243	CcSEcCtD
Formoterol—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000681	0.00242	CcSEcCtD
Formoterol—Angioedema—Prednisolone—ankylosing spondylitis	0.000679	0.00242	CcSEcCtD
Formoterol—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000677	0.00241	CcSEcCtD
Formoterol—Malaise—Prednisolone—ankylosing spondylitis	0.00067	0.00238	CcSEcCtD
Formoterol—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000669	0.00238	CcSEcCtD
Formoterol—Back pain—Triamcinolone—ankylosing spondylitis	0.000661	0.00235	CcSEcCtD
Formoterol—Asthma—Methotrexate—ankylosing spondylitis	0.000648	0.0023	CcSEcCtD
Formoterol—Hypertension—Prednisolone—ankylosing spondylitis	0.000642	0.00228	CcSEcCtD
Formoterol—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000636	0.00226	CcSEcCtD
Formoterol—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000636	0.00226	CcSEcCtD
Formoterol—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000634	0.00226	CcSEcCtD
Formoterol—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000633	0.00225	CcSEcCtD
Formoterol—Discomfort—Prednisolone—ankylosing spondylitis	0.000625	0.00222	CcSEcCtD
Formoterol—Angioedema—Triamcinolone—ankylosing spondylitis	0.000624	0.00222	CcSEcCtD
Formoterol—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000623	0.00222	CcSEcCtD
Formoterol—Malaise—Triamcinolone—ankylosing spondylitis	0.000616	0.00219	CcSEcCtD
Formoterol—Malaise—Methylprednisolone—ankylosing spondylitis	0.000615	0.00219	CcSEcCtD
Formoterol—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00061	0.00217	CcSEcCtD
Formoterol—Oedema—Prednisolone—ankylosing spondylitis	0.000606	0.00216	CcSEcCtD
Formoterol—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000606	0.00216	CcSEcCtD
Formoterol—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000602	0.00214	CcSEcCtD
Formoterol—Cough—Triamcinolone—ankylosing spondylitis	0.000596	0.00212	CcSEcCtD
Formoterol—Tachycardia—Prednisolone—ankylosing spondylitis	0.000592	0.00211	CcSEcCtD
Formoterol—Hypertension—Triamcinolone—ankylosing spondylitis	0.00059	0.0021	CcSEcCtD
Formoterol—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000589	0.00209	CcSEcCtD
Formoterol—Myalgia—Triamcinolone—ankylosing spondylitis	0.000582	0.00207	CcSEcCtD
Formoterol—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00058	0.00206	CcSEcCtD
Formoterol—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00058	0.00206	CcSEcCtD
Formoterol—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000578	0.00206	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000576	0.00205	CcSEcCtD
Formoterol—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000575	0.00205	CcSEcCtD
Formoterol—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000575	0.00205	CcSEcCtD
Formoterol—Discomfort—Triamcinolone—ankylosing spondylitis	0.000575	0.00204	CcSEcCtD
Formoterol—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000574	0.00204	CcSEcCtD
Formoterol—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000569	0.00202	CcSEcCtD
Formoterol—Angioedema—Betamethasone—ankylosing spondylitis	0.000567	0.00202	CcSEcCtD
Formoterol—Angioedema—Dexamethasone—ankylosing spondylitis	0.000567	0.00202	CcSEcCtD
Formoterol—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000561	0.002	CcSEcCtD
Formoterol—Immune system disorder—Prednisone—ankylosing spondylitis	0.00056	0.00199	CcSEcCtD
Formoterol—Malaise—Betamethasone—ankylosing spondylitis	0.000559	0.00199	CcSEcCtD
Formoterol—Malaise—Dexamethasone—ankylosing spondylitis	0.000559	0.00199	CcSEcCtD
Formoterol—Oedema—Triamcinolone—ankylosing spondylitis	0.000558	0.00198	CcSEcCtD
Formoterol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000558	0.00198	CcSEcCtD
Formoterol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000556	0.00198	CcSEcCtD
Formoterol—Arrhythmia—Prednisone—ankylosing spondylitis	0.000554	0.00197	CcSEcCtD
Formoterol—Infection—Triamcinolone—ankylosing spondylitis	0.000554	0.00197	CcSEcCtD
Formoterol—Infection—Methylprednisolone—ankylosing spondylitis	0.000553	0.00197	CcSEcCtD
Formoterol—Haematuria—Methotrexate—ankylosing spondylitis	0.000551	0.00196	CcSEcCtD
Formoterol—Insomnia—Prednisolone—ankylosing spondylitis	0.000549	0.00195	CcSEcCtD
Formoterol—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000546	0.00194	CcSEcCtD
Formoterol—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000544	0.00194	CcSEcCtD
Formoterol—Mental disorder—Prednisone—ankylosing spondylitis	0.000543	0.00193	CcSEcCtD
Formoterol—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000543	0.00193	CcSEcCtD
Formoterol—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00054	0.00192	CcSEcCtD
Formoterol—Malnutrition—Prednisone—ankylosing spondylitis	0.00054	0.00192	CcSEcCtD
Formoterol—Hypertension—Dexamethasone—ankylosing spondylitis	0.000535	0.0019	CcSEcCtD
Formoterol—Hypertension—Betamethasone—ankylosing spondylitis	0.000535	0.0019	CcSEcCtD
Formoterol—Myalgia—Dexamethasone—ankylosing spondylitis	0.000528	0.00188	CcSEcCtD
Formoterol—Myalgia—Betamethasone—ankylosing spondylitis	0.000528	0.00188	CcSEcCtD
Formoterol—Anxiety—Dexamethasone—ankylosing spondylitis	0.000526	0.00187	CcSEcCtD
Formoterol—Anxiety—Betamethasone—ankylosing spondylitis	0.000526	0.00187	CcSEcCtD
Formoterol—Discomfort—Dexamethasone—ankylosing spondylitis	0.000522	0.00186	CcSEcCtD
Formoterol—Discomfort—Betamethasone—ankylosing spondylitis	0.000522	0.00186	CcSEcCtD
Formoterol—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00052	0.00185	CcSEcCtD
Formoterol—Pain—Prednisolone—ankylosing spondylitis	0.000519	0.00184	CcSEcCtD
Formoterol—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000514	0.00183	CcSEcCtD
Formoterol—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000512	0.00182	CcSEcCtD
Formoterol—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000508	0.00181	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000508	0.00181	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000507	0.0018	CcSEcCtD
Formoterol—Oedema—Dexamethasone—ankylosing spondylitis	0.000506	0.0018	CcSEcCtD
Formoterol—Oedema—Betamethasone—ankylosing spondylitis	0.000506	0.0018	CcSEcCtD
Formoterol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000506	0.0018	CcSEcCtD
Formoterol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000506	0.0018	CcSEcCtD
Formoterol—Insomnia—Triamcinolone—ankylosing spondylitis	0.000504	0.00179	CcSEcCtD
Formoterol—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000503	0.00179	CcSEcCtD
Formoterol—Infection—Dexamethasone—ankylosing spondylitis	0.000503	0.00179	CcSEcCtD
Formoterol—Infection—Betamethasone—ankylosing spondylitis	0.000503	0.00179	CcSEcCtD
Formoterol—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000501	0.00178	CcSEcCtD
Formoterol—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0005	0.00178	CcSEcCtD
Formoterol—Visual impairment—Methotrexate—ankylosing spondylitis	0.0005	0.00178	CcSEcCtD
Formoterol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000497	0.00177	CcSEcCtD
Formoterol—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000496	0.00177	CcSEcCtD
Formoterol—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000496	0.00177	CcSEcCtD
Formoterol—Agitation—Prednisone—ankylosing spondylitis	0.000496	0.00177	CcSEcCtD
Formoterol—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000494	0.00176	CcSEcCtD
Formoterol—Tachycardia—Betamethasone—ankylosing spondylitis	0.000494	0.00176	CcSEcCtD
Formoterol—Angioedema—Prednisone—ankylosing spondylitis	0.000493	0.00176	CcSEcCtD
Formoterol—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000491	0.00175	CcSEcCtD
Formoterol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00049	0.00174	CcSEcCtD
Formoterol—Malaise—Prednisone—ankylosing spondylitis	0.000487	0.00173	CcSEcCtD
Formoterol—Urticaria—Prednisolone—ankylosing spondylitis	0.000482	0.00171	CcSEcCtD
Formoterol—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000481	0.00171	CcSEcCtD
Formoterol—Fatigue—Triamcinolone—ankylosing spondylitis	0.000481	0.00171	CcSEcCtD
Formoterol—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00048	0.00171	CcSEcCtD
Formoterol—Pain—Triamcinolone—ankylosing spondylitis	0.000477	0.0017	CcSEcCtD
Formoterol—Hypotension—Betamethasone—ankylosing spondylitis	0.000473	0.00168	CcSEcCtD
Formoterol—Hypotension—Dexamethasone—ankylosing spondylitis	0.000473	0.00168	CcSEcCtD
Formoterol—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000468	0.00167	CcSEcCtD
Formoterol—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000467	0.00166	CcSEcCtD
Formoterol—Hypertension—Prednisone—ankylosing spondylitis	0.000466	0.00166	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000461	0.00164	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000461	0.00164	CcSEcCtD
Formoterol—Myalgia—Prednisone—ankylosing spondylitis	0.00046	0.00164	CcSEcCtD
Formoterol—Arthralgia—Prednisone—ankylosing spondylitis	0.00046	0.00164	CcSEcCtD
Formoterol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00046	0.00163	CcSEcCtD
Formoterol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000459	0.00163	CcSEcCtD
Formoterol—Anxiety—Prednisone—ankylosing spondylitis	0.000458	0.00163	CcSEcCtD
Formoterol—Insomnia—Dexamethasone—ankylosing spondylitis	0.000458	0.00163	CcSEcCtD
Formoterol—Insomnia—Betamethasone—ankylosing spondylitis	0.000458	0.00163	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000457	0.00162	CcSEcCtD
Formoterol—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000455	0.00162	CcSEcCtD
Formoterol—Discomfort—Prednisone—ankylosing spondylitis	0.000454	0.00162	CcSEcCtD
Formoterol—Mental disorder—Methotrexate—ankylosing spondylitis	0.000454	0.00162	CcSEcCtD
Formoterol—Malnutrition—Methotrexate—ankylosing spondylitis	0.000451	0.00161	CcSEcCtD
Formoterol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000447	0.00159	CcSEcCtD
Formoterol—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000445	0.00158	CcSEcCtD
Formoterol—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000445	0.00158	CcSEcCtD
Formoterol—Urticaria—Triamcinolone—ankylosing spondylitis	0.000443	0.00158	CcSEcCtD
Formoterol—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000442	0.00157	CcSEcCtD
Formoterol—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000442	0.00157	CcSEcCtD
Formoterol—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000441	0.00157	CcSEcCtD
Formoterol—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000441	0.00157	CcSEcCtD
Formoterol—Oedema—Prednisone—ankylosing spondylitis	0.000441	0.00157	CcSEcCtD
Formoterol—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00044	0.00156	CcSEcCtD
Formoterol—Infection—Prednisone—ankylosing spondylitis	0.000438	0.00156	CcSEcCtD
Formoterol—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000437	0.00155	CcSEcCtD
Formoterol—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000437	0.00155	CcSEcCtD
Formoterol—Back pain—Methotrexate—ankylosing spondylitis	0.000437	0.00155	CcSEcCtD
Formoterol—Fatigue—Betamethasone—ankylosing spondylitis	0.000436	0.00155	CcSEcCtD
Formoterol—Fatigue—Dexamethasone—ankylosing spondylitis	0.000436	0.00155	CcSEcCtD
Formoterol—Pain—Betamethasone—ankylosing spondylitis	0.000433	0.00154	CcSEcCtD
Formoterol—Pain—Dexamethasone—ankylosing spondylitis	0.000433	0.00154	CcSEcCtD
Formoterol—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000432	0.00154	CcSEcCtD
Formoterol—Tachycardia—Prednisone—ankylosing spondylitis	0.00043	0.00153	CcSEcCtD
Formoterol—Skin disorder—Prednisone—ankylosing spondylitis	0.000428	0.00152	CcSEcCtD
Formoterol—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000419	0.00149	CcSEcCtD
Formoterol—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000417	0.00148	CcSEcCtD
Formoterol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000417	0.00148	CcSEcCtD
Formoterol—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000414	0.00147	CcSEcCtD
Formoterol—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000414	0.00147	CcSEcCtD
Formoterol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000411	0.00146	CcSEcCtD
Formoterol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00041	0.00146	CcSEcCtD
Formoterol—Malaise—Methotrexate—ankylosing spondylitis	0.000407	0.00145	CcSEcCtD
Formoterol—Urticaria—Betamethasone—ankylosing spondylitis	0.000402	0.00143	CcSEcCtD
Formoterol—Urticaria—Dexamethasone—ankylosing spondylitis	0.000402	0.00143	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000401	0.00143	CcSEcCtD
Formoterol—Dizziness—Prednisolone—ankylosing spondylitis	0.000401	0.00143	CcSEcCtD
Formoterol—Asthenia—Triamcinolone—ankylosing spondylitis	0.0004	0.00142	CcSEcCtD
Formoterol—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.0004	0.00142	CcSEcCtD
Formoterol—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.0004	0.00142	CcSEcCtD
Formoterol—Abdominal pain—Betamethasone—ankylosing spondylitis	0.0004	0.00142	CcSEcCtD
Formoterol—Body temperature increased—Betamethasone—ankylosing spondylitis	0.0004	0.00142	CcSEcCtD
Formoterol—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000399	0.00142	CcSEcCtD
Formoterol—Insomnia—Prednisone—ankylosing spondylitis	0.000399	0.00142	CcSEcCtD
Formoterol—Pruritus—Triamcinolone—ankylosing spondylitis	0.000395	0.0014	CcSEcCtD
Formoterol—Cough—Methotrexate—ankylosing spondylitis	0.000394	0.0014	CcSEcCtD
Formoterol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000394	0.0014	CcSEcCtD
Formoterol—Dyspepsia—Prednisone—ankylosing spondylitis	0.000388	0.00138	CcSEcCtD
Formoterol—Chest pain—Methotrexate—ankylosing spondylitis	0.000384	0.00137	CcSEcCtD
Formoterol—Arthralgia—Methotrexate—ankylosing spondylitis	0.000384	0.00137	CcSEcCtD
Formoterol—Myalgia—Methotrexate—ankylosing spondylitis	0.000384	0.00137	CcSEcCtD
Formoterol—Rash—Prednisolone—ankylosing spondylitis	0.000382	0.00136	CcSEcCtD
Formoterol—Dermatitis—Prednisolone—ankylosing spondylitis	0.000382	0.00136	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000382	0.00136	CcSEcCtD
Formoterol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000381	0.00135	CcSEcCtD
Formoterol—Fatigue—Prednisone—ankylosing spondylitis	0.00038	0.00135	CcSEcCtD
Formoterol—Headache—Prednisolone—ankylosing spondylitis	0.00038	0.00135	CcSEcCtD
Formoterol—Discomfort—Methotrexate—ankylosing spondylitis	0.00038	0.00135	CcSEcCtD
Formoterol—Constipation—Prednisone—ankylosing spondylitis	0.000377	0.00134	CcSEcCtD
Formoterol—Dizziness—Triamcinolone—ankylosing spondylitis	0.000369	0.00131	CcSEcCtD
Formoterol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000368	0.00131	CcSEcCtD
Formoterol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000368	0.00131	CcSEcCtD
Formoterol—Infection—Methotrexate—ankylosing spondylitis	0.000366	0.0013	CcSEcCtD
Formoterol—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000363	0.00129	CcSEcCtD
Formoterol—Asthenia—Betamethasone—ankylosing spondylitis	0.000363	0.00129	CcSEcCtD
Formoterol—Asthenia—Dexamethasone—ankylosing spondylitis	0.000363	0.00129	CcSEcCtD
Formoterol—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000361	0.00128	CcSEcCtD
Formoterol—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00036	0.00128	CcSEcCtD
Formoterol—Nausea—Prednisolone—ankylosing spondylitis	0.00036	0.00128	CcSEcCtD
Formoterol—Pruritus—Dexamethasone—ankylosing spondylitis	0.000358	0.00127	CcSEcCtD
Formoterol—Pruritus—Betamethasone—ankylosing spondylitis	0.000358	0.00127	CcSEcCtD
Formoterol—Skin disorder—Methotrexate—ankylosing spondylitis	0.000358	0.00127	CcSEcCtD
Formoterol—Vomiting—Triamcinolone—ankylosing spondylitis	0.000355	0.00126	CcSEcCtD
Formoterol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000354	0.00126	CcSEcCtD
Formoterol—Rash—Triamcinolone—ankylosing spondylitis	0.000352	0.00125	CcSEcCtD
Formoterol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000351	0.00125	CcSEcCtD
Formoterol—Rash—Methylprednisolone—ankylosing spondylitis	0.000351	0.00125	CcSEcCtD
Formoterol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000351	0.00125	CcSEcCtD
Formoterol—Urticaria—Prednisone—ankylosing spondylitis	0.00035	0.00125	CcSEcCtD
Formoterol—Headache—Triamcinolone—ankylosing spondylitis	0.000349	0.00124	CcSEcCtD
Formoterol—Headache—Methylprednisolone—ankylosing spondylitis	0.000349	0.00124	CcSEcCtD
Formoterol—Body temperature increased—Prednisone—ankylosing spondylitis	0.000348	0.00124	CcSEcCtD
Formoterol—Abdominal pain—Prednisone—ankylosing spondylitis	0.000348	0.00124	CcSEcCtD
Formoterol—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000346	0.00123	CcSEcCtD
Formoterol—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000346	0.00123	CcSEcCtD
Formoterol—Hypotension—Methotrexate—ankylosing spondylitis	0.000344	0.00122	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000336	0.00119	CcSEcCtD
Formoterol—Dizziness—Dexamethasone—ankylosing spondylitis	0.000335	0.00119	CcSEcCtD
Formoterol—Dizziness—Betamethasone—ankylosing spondylitis	0.000335	0.00119	CcSEcCtD
Formoterol—Insomnia—Methotrexate—ankylosing spondylitis	0.000333	0.00119	CcSEcCtD
Formoterol—Nausea—Triamcinolone—ankylosing spondylitis	0.000331	0.00118	CcSEcCtD
Formoterol—Nausea—Methylprednisolone—ankylosing spondylitis	0.000331	0.00118	CcSEcCtD
Formoterol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000328	0.00117	CcSEcCtD
Formoterol—Somnolence—Methotrexate—ankylosing spondylitis	0.000327	0.00116	CcSEcCtD
Formoterol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000325	0.00116	CcSEcCtD
Formoterol—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000324	0.00115	CcSEcCtD
Formoterol—Vomiting—Dexamethasone—ankylosing spondylitis	0.000322	0.00114	CcSEcCtD
Formoterol—Vomiting—Betamethasone—ankylosing spondylitis	0.000322	0.00114	CcSEcCtD
Formoterol—Rash—Dexamethasone—ankylosing spondylitis	0.000319	0.00114	CcSEcCtD
Formoterol—Rash—Betamethasone—ankylosing spondylitis	0.000319	0.00114	CcSEcCtD
Formoterol—Dermatitis—Betamethasone—ankylosing spondylitis	0.000319	0.00113	CcSEcCtD
Formoterol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000319	0.00113	CcSEcCtD
Formoterol—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000318	0.00113	CcSEcCtD
Formoterol—Fatigue—Methotrexate—ankylosing spondylitis	0.000318	0.00113	CcSEcCtD
Formoterol—Headache—Betamethasone—ankylosing spondylitis	0.000317	0.00113	CcSEcCtD
Formoterol—Headache—Dexamethasone—ankylosing spondylitis	0.000317	0.00113	CcSEcCtD
Formoterol—Asthenia—Prednisone—ankylosing spondylitis	0.000316	0.00112	CcSEcCtD
Formoterol—Pain—Methotrexate—ankylosing spondylitis	0.000315	0.00112	CcSEcCtD
Formoterol—Pruritus—Prednisone—ankylosing spondylitis	0.000312	0.00111	CcSEcCtD
Formoterol—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000303	0.00108	CcSEcCtD
Formoterol—Diarrhoea—Prednisone—ankylosing spondylitis	0.000302	0.00107	CcSEcCtD
Formoterol—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000301	0.00107	CcSEcCtD
Formoterol—Nausea—Dexamethasone—ankylosing spondylitis	0.000301	0.00107	CcSEcCtD
Formoterol—Nausea—Betamethasone—ankylosing spondylitis	0.000301	0.00107	CcSEcCtD
Formoterol—Urticaria—Methotrexate—ankylosing spondylitis	0.000293	0.00104	CcSEcCtD
Formoterol—Dizziness—Prednisone—ankylosing spondylitis	0.000291	0.00104	CcSEcCtD
Formoterol—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000291	0.00104	CcSEcCtD
Formoterol—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000291	0.00104	CcSEcCtD
Formoterol—Vomiting—Prednisone—ankylosing spondylitis	0.00028	0.000997	CcSEcCtD
Formoterol—Rash—Prednisone—ankylosing spondylitis	0.000278	0.000988	CcSEcCtD
Formoterol—Dermatitis—Prednisone—ankylosing spondylitis	0.000278	0.000988	CcSEcCtD
Formoterol—Headache—Prednisone—ankylosing spondylitis	0.000276	0.000982	CcSEcCtD
Formoterol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000271	0.000965	CcSEcCtD
Formoterol—Asthenia—Methotrexate—ankylosing spondylitis	0.000264	0.00094	CcSEcCtD
Formoterol—Nausea—Prednisone—ankylosing spondylitis	0.000262	0.000931	CcSEcCtD
Formoterol—Pruritus—Methotrexate—ankylosing spondylitis	0.000261	0.000927	CcSEcCtD
Formoterol—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000252	0.000896	CcSEcCtD
Formoterol—Dizziness—Methotrexate—ankylosing spondylitis	0.000244	0.000866	CcSEcCtD
Formoterol—Vomiting—Methotrexate—ankylosing spondylitis	0.000234	0.000833	CcSEcCtD
Formoterol—Rash—Methotrexate—ankylosing spondylitis	0.000232	0.000826	CcSEcCtD
Formoterol—Dermatitis—Methotrexate—ankylosing spondylitis	0.000232	0.000825	CcSEcCtD
Formoterol—Headache—Methotrexate—ankylosing spondylitis	0.000231	0.000821	CcSEcCtD
Formoterol—Nausea—Methotrexate—ankylosing spondylitis	0.000219	0.000778	CcSEcCtD
